1-6 of 6
Amy O'Sullivan
Close
Sort by
Journal Articles

Lenalidomide and Dexamethasone Alone Is Equivalent To Lenalidomide and Dexamethasone With Autologous Stem Cell Transplant In Newly Diagnosed Multiple Myeloma: Interim Study Results Of a Randomized Trial

Jordan M. Schecter, MD, Kristen Kipps, MD, Amy O'Sullivan, BS, BSN, MSW, Kent A. Griffith, MPH, MS, Daniel Normolle, PhD, Markus Mapara, MD, PhD, Robert Redner, MD, Suzanne Lentzsch, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3180.
https://doi.org/10.1182/blood.V122.21.3180.3180
Published: 2013
Journal Articles

Combination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: results of phase 1/2 open-label, dose escalation study

Clinical Trials & Observations
Suzanne Lentzsch, Amy O'Sullivan, Ryan C. Kennedy, Mohammad Abbas, Lijun Dai, Silvana Lalo Pregja, Steve Burt, Michael Boyiadzis, G. David Roodman, Markus Y. Mapara, Mounzer Agha, John Waas, Yongli Shuai, Daniel Normolle, Jeffrey A. Zonder
Journal: Blood
Blood (2012) 119 (20): 4608–4613.
https://doi.org/10.1182/blood-2011-12-395715
Published: 2012
Journal Articles

A Randomized Clinical Trial of Lenalidomide and Dexamethasone with and without Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma: Interim Study Results,

Lijun Dai, MD, PhD, Amy O'Sullivan, RN, BSN, Ryan Kennedy, BS, Mohammad Abbas, MD, Yongli Shuai, MS, Vida Almario Passero, MD, Carrie Andreas, PA-C, Diane Gardner, MSN, CRNP, BC, Robert L Redner, MD, G. David Roodman, MD, PhD, Stanley M. Marks, MD, Anastasios Raptis, MD, Jing-Zhou Hou, MD, PhD, Daniel Petro, MD, Min Sun, MD, PhD, Terry Evans, MD, Louis V. Pietragallo, MD, John K. Waas, DO, J. Franklin Viverette, MD, Jennifer Osborn, MD, Vincent Reyes, MD, Richard Pinkerton, DO, Theodore Crandall, MD, Ronald Fierro, MD, Robert Volkin, MD, Daniel Normolle, PhD, Markus Y. Mapara, MD, PhD, Suzanne Lentzsch, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4142.
https://doi.org/10.1182/blood.V118.21.4142.4142
Published: 2011
Journal Articles

Combination of Bendamustine, Lenalidomide, and Dexamethasone (BLD) in Patients with Refractory or Relapsed Multiple Myeloma Is Safe and Highly Effective: Results of Phase I/II Open-Label, Dose Escalation Study

Suzanne Lentzsch, MD, PhD, Amy O'Sullivan, RN, BSN, Ryan Kennedy, BS, Mohammad Abbas, MD, Navkiranjit Gill, DO, Lijun Dai, MD, PhD, Carrie Andreas, PA-C, Diane Gardner, MSN, CRNP, BC, Silvana Lalo Pregja, MBA, Steve Burt, NP, Robert L. Redner, MD, Robert Volkin, MD, G. David Roodman, MD, PhD, Markus Y. Mapara, MD, PhD, J. Franklin Viverette, MD, Mounzer Agha, MD, John K. Waas, DO, Yongli Shuai, MS, Daniel Normolle, PhD, Jeffrey A. Zonder, MD
Journal: Blood
Blood (2011) 118 (21): 304.
https://doi.org/10.1182/blood.V118.21.304.304
Published: 2011
Journal Articles

Combination of Bendamustine, Lenalidomide, and Dexamethasone In Patients with Refractory or Relapsed Multiple Myeloma Is Safe and Highly Effective: Results of a Phase I Clinical Trial

Suzanne Lentzsch, MD, PhD, Amy O'Sullivan, RN, BSN, Ryan Kennedy, BS, Navkiranjit Gill, DO, Carrie Andreas, PA-C, Diane Gardner, MSN, CRNP, BC, Silvana Lalo, MBA, Steve Burt, NP, Robert L. Redner, MD, Robert Volkin, MD, David Roodman, MD, PhD, Markus Y Mapara, MD, PhD, Frank Viverette, MD, Mounzer Agha, MD, Jeffrey A. Zonder, MD
Journal: Blood
Blood (2010) 116 (21): 989.
https://doi.org/10.1182/blood.V116.21.989.989
Published: 2010
Journal Articles

A Phase I Study of Bendamustine Combined with Lenalidomide and Dexamethasone in Patients with Refractory or Relapsed Multiple Myeloma.

Suzanne Lentzsch, MD, PhD, Amy O’Sullivan, RN, BSN, Silvana Lalo, MBA, Carrie Kruppa, MPAS, PA-C, Diane Gardner, RN, CRNP, Ryan C Kennedy, BS, Steve Burt, NP, Markus Y Mapara, MD, PhD, Robert Redner, MD, David Roodman, MD, PhD, Robert L Volkin, MD, Jeffrey Zonder, MD
Journal: Blood
Blood (2009) 114 (22): 1856.
https://doi.org/10.1182/blood.V114.22.1856.1856
Published: 2009